The mFluiDx platform is fully autonomous, smart-phone enabled unit ideal for on-site testing. Also, Injection molding allows mass production of chips at cost 1000 times lower than PCR. In addition, sothermal nucleic acid amplification allows sensitivity comparable to PCR. So, with quick and accurate results the platform allows real-time tracking of outbreak, conveying important information during most crucial times of outbreak.